title: The Sterways process: a new approach to inactivating viruses using gamma radiation.
abstract: The Sterways process (Process) provides a means of terminally sterilizing and virally inactivating blood products. The Process uses gamma radiation in a controlled manner to achieve maximum viral kill with minimum product loss. This goal is achieved by controlling the dose rate for the particular product and formulation in question. Because the Process uses gamma radiation it not only inactivates known viruses but also emerging or mutilating viruses.
authors.affiliation: Gamma Irradiation, Sterways Pioneer Inc., Suite 2001 130 Albert Street, Ottawa, ON K1P 5G4, Canada.
authors.forename: B D
authors.initials: BD
authors.lastname: Reid
mesh_terms: D000818:Animals; D002417:Cattle; D001908:Diarrhea Viruses, Bovine Viral / Q000302:isolation & purification / Q000528:radiation effects; D004307:Dose-Response Relationship, Radiation; D004340:Drug Contamination / Q000517:prevention & control; D005169:Factor VIII / Q000302:isolation & purification; D005340:Fibrinogen / Q000302:isolation & purification; D005720:Gamma Rays; D006801:Humans; D010321:Parvoviridae / Q000302:isolation & purification / Q000528:radiation effects; D012709:Serum Albumin / Q000302:isolation & purification; D013242:Sterilization / Q000379:methods*; D013552:Swine; D014773:Virology / Q000379:methods*; D014780:Viruses / Q000302:isolation & purification / Q000472:pathogenicity / Q000528:radiation effects*; D000515:alpha 1-Antitrypsin / Q000302:isolation & purification
chemical_list: D012709:Serum Albumin; D000515:alpha 1-Antitrypsin; D005169:Factor VIII; D005340:Fibrinogen